Author: Yoshihara, T.; Ito, K.; Zaitsu, M.; Chung, E.; Aoyagi, I.; Kaji, R.; Tsuru, T.; Yonemura, T.; Yamaguchi, K.; Nakayama, S.; Tanaka, Y.; Yurino, N.; Koyanagi, H.; Matsuki, S.; Urae, R.; Irie, S.
Title: SARS-CoV-2 seroprevalence among healthcare workers in general hospitals and clinics in Japan Cord-id: bgn0kwe1 Document date: 2021_1_25
ID: bgn0kwe1
Snippet: Coronavirus disease 2019 (COVID-19) has become a serious public health problem worldwide. However, little is known about the prevalence of COVID-19 among healthcare workers in Japan. We aimed to examine the seroprevalence of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) antibodies among 2,160 healthcare workers in general hospitals and clinics in Japan. The prevalence of SARS-CoV-2 immunoglobulin G was 1.2% in August and October 2020, which is relatively higher than that in the ge
Document: Coronavirus disease 2019 (COVID-19) has become a serious public health problem worldwide. However, little is known about the prevalence of COVID-19 among healthcare workers in Japan. We aimed to examine the seroprevalence of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) antibodies among 2,160 healthcare workers in general hospitals and clinics in Japan. The prevalence of SARS-CoV-2 immunoglobulin G was 1.2% in August and October 2020, which is relatively higher than that in the general population in Japan. Because of the higher risk of COVID-19 infection, healthcare workers should be the top priority for further social support and vaccination against SARS-CoV-2.
Search related documents:
Co phrase search for related documents- Try single phrases listed below for: 1
Co phrase search for related documents, hyperlinks ordered by date